Jun 17, 2020
BioMarin Provides Additional Data from Recent 4 Year Update of Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A in Late-Breaking Oral Presentation at World Federation of Hemophilia Virtual Summit
Jun 16, 2020
CAR-T Therapy Market Outlook to 2030 by Target Antigen, Application, Region, Country and Company
Jun 11, 2020
Sexton Biotechnologies Partners with BioSpherix to Create a Fully-Enclosed, Modular Fill-Finish System with Rapid Deployment for Emerging Cell and Gene Therapy Needs
Jun 01, 2020
Aruvant Appoints Dr. Palaniappan as Chief Technology Officer
May 31, 2020
BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
May 29, 2020
Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO)
May 28, 2020
global market for viral vector and plasmid manufacturing is predicted to grow at a CAGR of 16.28% over the forecast period of 2020-2030
May 27, 2020
Wize Pharma's Strategic Transaction Partner Bonus BioGroup to Present MesenCure Data at the International Society for Cell & Gene Therapy (ISCT) Annual Meeting on May 28-29, 2020
May 27, 2020
Evox Therapeutics Appoints Martin Andrews as Non-Executive Director
May 26, 2020
Beacon Targeted Therapies Launches Its Latest Clinical Trial and Drug Database Solution - Beacon Gene Therapy
May 20, 2020
Catalent to Present Assessment Methods and Design Approaches for T-Cell Manufacturing Challenges at ISCT 2020 Virtual
May 18, 2020
MaxCyte to Share Preliminary Phase I Data on MCY-M11 at ASCO 2020 Annual Meeting
May 18, 2020
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
May 18, 2020
Triphase Accelerator and Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial of TRPH-222 in Patients with Non-Hodgkin's Lymphoma
May 15, 2020
GEMoaB Announces Data Presentations Supporting Key Features of Its UniCAR Platform At the Upcoming American Association for Cancer Research (AACR) Meeting II
May 12, 2020
Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases
May 11, 2020
Aruvant Appoints Joseph McIntosh, M.D. as Chief Medical Officer
May 07, 2020
REGENXBIO Reports First Quarter 2020 Financial Results and Operational Highlights
May 07, 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
May 03, 2020
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies